Phase II Study: Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
time to relapse
36 months
Yes
Bernard TĂȘtu, MD
Principal Investigator
Université Laval
Canada: Health Canada
SC-126639
NCT00721890
June 2008
June 2014
Name | Location |
---|